Middle Meningeal Artery Embolization for Refractory Chronic Subdural Hematoma Associated with Acute Myeloid Leukemia: A Case Report.

Journal of neuroendovascular therapy Pub Date : 2024-01-01 Epub Date: 2024-01-13 DOI:10.5797/jnet.cr.2023-0084
Atsuhiro Kojima, Masataka Hosoi, Kanako Hayashi, Mariko Fukumura, Isako Saga
{"title":"Middle Meningeal Artery Embolization for Refractory Chronic Subdural Hematoma Associated with Acute Myeloid Leukemia: A Case Report.","authors":"Atsuhiro Kojima, Masataka Hosoi, Kanako Hayashi, Mariko Fukumura, Isako Saga","doi":"10.5797/jnet.cr.2023-0084","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>We describe a patient with leukemia-related chronic subdural hematoma (CSDH) who was successfully treated using the combination of surgical evacuation and middle meningeal artery (MMA) embolization.</p><p><strong>Case presentation: </strong>A 73-year-old man without apparent head trauma history was admitted to our hospital because of acute myeloid leukemia (AML). Head CT on admission revealed mild CSDH on both sides. Medical treatment options, including chemotherapy, were started. Since a decrease in platelet count and disseminated intravascular coagulation were observed on day 4, recombinant thrombomodulin was administered. As the patient exhibited signs of altered consciousness due to the enlargement of the right CSDH on day 10, we performed surgical drainage. Despite subsequent platelet transfusion and administration of goreisan, the right CSDH recurred within a short period. On day 17, we performed the second surgery and MMA embolization in one stage. The postoperative clinical course was favorable without recurrence of the hematoma. The patient eventually died on day 123 from a deterioration of his general condition.</p><p><strong>Conclusion: </strong>Although MMA embolization has recently been recognized as an effective treatment option for recurrent CSDH, there are no published reports addressing the efficacy of MMA embolization for refractory CSDH associated with hematological malignancies. Findings from the management of this case suggest that MMA embolization can be the effective treatment option for CSDH in patients with severe hemorrhagic diathesis due to AML.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 2","pages":"47-52"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10878736/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neuroendovascular therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5797/jnet.cr.2023-0084","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/13 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: We describe a patient with leukemia-related chronic subdural hematoma (CSDH) who was successfully treated using the combination of surgical evacuation and middle meningeal artery (MMA) embolization.

Case presentation: A 73-year-old man without apparent head trauma history was admitted to our hospital because of acute myeloid leukemia (AML). Head CT on admission revealed mild CSDH on both sides. Medical treatment options, including chemotherapy, were started. Since a decrease in platelet count and disseminated intravascular coagulation were observed on day 4, recombinant thrombomodulin was administered. As the patient exhibited signs of altered consciousness due to the enlargement of the right CSDH on day 10, we performed surgical drainage. Despite subsequent platelet transfusion and administration of goreisan, the right CSDH recurred within a short period. On day 17, we performed the second surgery and MMA embolization in one stage. The postoperative clinical course was favorable without recurrence of the hematoma. The patient eventually died on day 123 from a deterioration of his general condition.

Conclusion: Although MMA embolization has recently been recognized as an effective treatment option for recurrent CSDH, there are no published reports addressing the efficacy of MMA embolization for refractory CSDH associated with hematological malignancies. Findings from the management of this case suggest that MMA embolization can be the effective treatment option for CSDH in patients with severe hemorrhagic diathesis due to AML.

脑膜中动脉栓塞术治疗急性髓性白血病相关的难治性慢性硬膜下血肿:病例报告。
目的:我们描述了一名白血病相关慢性硬膜下血肿(CSDH)患者:我们描述了一名与白血病相关的慢性硬膜下血肿(CSDH)患者,该患者通过手术清除和脑膜中动脉(MMA)栓塞联合治疗获得成功:一名无明显头部外伤史的 73 岁男性因急性髓性白血病(AML)入住我院。入院时头部 CT 显示双侧轻度 CSDH。开始接受包括化疗在内的药物治疗。由于第 4 天观察到血小板计数下降和弥散性血管内凝血,因此给患者注射了重组血栓调节蛋白。由于患者在第 10 天因右侧 CSDH 扩大而出现意识改变的迹象,我们对其进行了手术引流。尽管随后输注了血小板并服用了戈瑞散,但右侧 CSDH 还是在短时间内复发。第 17 天,我们进行了第二次手术,并一期进行了 MMA 栓塞。术后临床过程良好,血肿未复发。患者最终于第 123 天因全身状况恶化而死亡:尽管 MMA 栓塞术最近被认为是治疗复发性 CSDH 的有效方法,但目前还没有关于 MMA 栓塞术对血液恶性肿瘤相关的难治性 CSDH 的疗效的公开报道。本病例的治疗结果表明,MMA栓塞术是治疗因急性髓细胞白血病导致严重出血的 CSDH 患者的有效方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信